InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

PALISADE BIO, INC.

PALI Clue Score57
United States Fiscal year ends December CIK 0001357459 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Donald Allen Williams
2 Oct 2026
Director
Buy
10,000
$1.46
$14.60K
Donald Allen Williams
1 Oct 2026
Director
Buy
10,000
$1.42
$14.20K
Robert Baltera Jr.
9 Jul 2026
Director
Buy
25,000
$1.96
$48.90K
Robert Baltera Jr.
8 Jul 2026
Director
Buy
20,000
$1.99
$39.80K
John David Finley
7 Jul 2026
CEO, CFO
Sold after exercise
146,798
$2.07
$303.34K
Mitchell Lawrence Jones
7 Jul 2026
Chief Medical Officer
Sell
51,880
$2.05
$106.54K
Robert Baltera Jr.
7 Jul 2026
Director
Buy
30,000
$2.03
$61.04K
Robert Baltera Jr.
6 Jul 2026
Director
Buy
20,000
$2.05
$41.04K
Robert Baltera Jr.
2 Jul 2026
Director
Buy
10,000
$1.98
$19.80K
Robert Baltera Jr.
1 Jul 2026
Director
Buy
20,000
$1.98
$39.60K
John David Finley
12 Feb 2026
CEO, CFO
Sell
3,896
$1.75
$6.82K
Mitchell Lawrence Jones
12 Feb 2026
Chief Medical Officer
Sell
1,989
$1.75
$3.48K
Donald Allen Williams
16 Jan 2026
Director
Buy
5,000
$1.67
$8.36K
Donald Allen Williams
9 Jan 2026
Director
Buy
5,000
$1.88
$9.40K

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 13,201,592
History held since 19 Mar 2007